Erman Akkus/X
Mar 16, 2025, 12:10
Erman Akkus: BMI and survival with immune checkpoint inhibitors
Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article by Eric V. Mastrolonardo, et al. on X:
“BMI and survival with immune checkpoint inhibitors.
- 18,434 patients
- BMI >30 vs 20-24.9
- OS with obesity
- HR: 0.69 (0.66–0.72)
except RCC.”
Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types.
Authors: Eric V. Mastrolonardo, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26